Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

555 questions in 79 reviews · Musculoskeletal

current versions
No studies 555 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Febuxostat 120 mg/day vs allopurinol
Patient global assessment · patients with chronic gout
Febuxostat for treating chronic gout (2012) · Cochrane
no estimate extractedNRNo studies
Febuxostat 40 mg/day vs placebo
Patient global assessment · patients with chronic gout
Febuxostat for treating chronic gout (2012) · Cochrane
no estimate extractedNRNo studies
Febuxostat 120 mg/day vs allopurinol
Health Related Quality of Life · patients with chronic gout
Febuxostat for treating chronic gout (2012) · Cochrane
no estimate extractedNRNo studies
Febuxostat 40 mg/day vs placebo
Health Related Quality of Life · patients with chronic gout
Febuxostat for treating chronic gout (2012) · Cochrane
no estimate extractedNRNo studies
MAOIs vs placebo
Physical function · patients with fibromyalgia syndrome
Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome (2012) · Cochrane
no estimate extractedNRNo studies
MAOIs vs placebo
Sleep disturbance · patients with fibromyalgia syndrome
Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome (2012) · Cochrane
no estimate extractedNRNo studies
Intervention NR
ACR 50% improvement ‐ not measured · patients with treating rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Change in radiographic progression ‐ not measured · patients with Rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Achievement of low disease state (DAS 28) ‐ not measured · patients with Rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Change in radiographic progression ‐ not measured · patients with treating rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Achievement of low disease state (DAS 28) ‐ not measured · patients with treating rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Change in pain ‐ not measured · patients with Rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
HAQ disability score ‐ not measured · patients with Rheumatoid arthritis
Herbal therapy for treating rheumatoid arthritis (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pain ‐ not measured · patients with chronic (>12 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pain ‐ not reported · patients with chronic (>6 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Disabilty ‐ not measured · patients with chronic (>6 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events ‐ not measured · patients with chronic (>6 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events ‐ not measured · patients with chronic (>12 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events ‐ not reported · patients with lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pain ‐ not reported · patients with chronic (mean 23 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Disability ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain
Surgery for lateral elbow pain (2011) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events · Patients with knee osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Side effects of acupuncture‐Bruising and bleeding at injection site · Patients with knee osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events · Patients with peripheral joint osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Side effects of acupuncture‐Bruising and bleeding at injection site · Patients with peripheral joint osteoarthritis
Acupuncture for peripheral joint osteoarthritis (2010) · Cochrane
no estimate extractedNRNo studies
Augmented subscapularis transposition vs subscapularis transposition alone during total shoulder arthroplasty
Quality of life ‐ not reported · Patients with rheumatoid shoulder
Surgical interventions for the rheumatoid shoulder (2010) · Cochrane
no estimate extractedNRNo studies
Augmented subscapularis transposition vs subscapularis transposition alone during total shoulder arthroplasty
Component loosening / revisions ‐ not reported · Patients with rheumatoid shoulder
Surgical interventions for the rheumatoid shoulder (2010) · Cochrane
no estimate extractedNRNo studies
Augmented subscapularis transposition vs subscapularis transposition alone during total shoulder arthroplasty
Other complications ‐ not reported · Patients with rheumatoid shoulder
Surgical interventions for the rheumatoid shoulder (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse events3 ‐ not reported · patients with improving bone mineral density in children
Vitamin D supplementation for improving bone mineral density in children (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Patient Satisfaction ‐ not measured · for quadriceps strengthening pre and post total knee replacement
Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Pain ‐ not measured · for quadriceps strengthening pre and post total knee replacement
Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse effects ‐ burns, skin damage, or cardiac arrhythmias ‐ not measured · for quadriceps strengthening pre and post total knee replacement
Surface neuromuscular electrical stimulation for quadriceps strengthening pre and post total knee replacement (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Physical Function ‐ not measured · patients with big toe joint osteoarthritis
Interventions for treating osteoarthritis of the big toe joint (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Adverse effects ( · patients with big toe joint osteoarthritis
Interventions for treating osteoarthritis of the big toe joint (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Disability/function ‐ not reported · patients with shoulder pain
Botulinum toxin for shoulder pain (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
WIthdrawals due to Adverse Events ‐ not reported · patients with shoulder pain
Botulinum toxin for shoulder pain (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
Serious Adverse Events ‐ not reported · patients with shoulder pain
Botulinum toxin for shoulder pain (2010) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 5 mg/day vs placebo
Benefits · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation
Function ‐ not measured · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation
Harms · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic
Benefits · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic
Pain ‐ not reported1 · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic
Function ‐ not measured · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 5 mg/day vs injection with corticosteroid and anaesthetic
Harms · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 5 mg/day vs placebo
Function ‐ not measured · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 5 mg/day vs placebo
Harms · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 5 mg/day vs placebo
Headache ‐ not reported4 · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation
Benefits · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies
Summary of findings: 1.25 mg/day plus rehabilitation vs placebo plus rehabilitation
Pain ‐ not reported1 · People with rotator cuff disease
Topical glyceryl trinitrate for rotator cuff disease (2009) · Cochrane
no estimate extractedNRNo studies